Stock LINCOLN LINCOLN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Lincoln Pharmaceuticals Limited NSE India S.E.

Equities

LINCOLN

INE405C01035

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-05-07 am EDT 		5-day change 1st Jan Change
585.7 INR -0.88% Intraday chart for Lincoln Pharmaceuticals Limited -1.41% -3.90%
Mar. 30 Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director CI
Feb. 22 Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director CI

Business Summary

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceuticals products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.

Number of employees: 1,645

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
4,721 100.0 % 5,103 100.0 % +8.09%

Sales per region

INR in Million2022Weight2023Weight Delta
Rest of World
57.4 %
2,665 56.5 % 2,931 57.4 % +9.96%
India
42.6 %
2,056 43.5 % 2,172 42.6 % +5.65%

Managers

Managers TitleAgeSince
Mahendrabhai Gulabda Patel CEO
 Chief Executive Officer 70 95-01-19
Darshit Ashvinkumar Shah DFI
 Director of Finance/CFO - 19-03-27
Laxmikant Harsola CTO
 Chief Tech/Sci/R&D Officer - -
Trusha Deepak Shah CMP
 Compliance Officer 30 22-11-09
Isha Sanjiv Patel ADM
 Chief Administrative Officer - -
Dhaval Gandhi CTO
 Chief Tech/Sci/R&D Officer - -
Ashish Rajnikant Patel BRD
 Director/Board Member 43 -
Munjal Mahendrabhai Patel BRD
 Director/Board Member 41 14-11-13
Rajnikant Gulabdas Patel BRD
 Director/Board Member 66 95-01-19
Bhavesh Patel SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Mahendrabhai Gulabda Patel CEO
 Chief Executive Officer 70 95-01-19
Kishorbhai Meghjibha Shah CHM
 Chairman 80 95-08-15
Rajnikant Gulabdas Patel BRD
 Director/Board Member 66 95-01-19
Munjal Mahendrabhai Patel BRD
 Director/Board Member 41 14-11-13
Ashish Rajnikant Patel BRD
 Director/Board Member 43 -
Saurin Jagdishbhai Parikh BRD
 Director/Board Member 52 18-03-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,029,728 8,821,793 ( 44.04 %) 0 44.04 %

Shareholders

NameEquities%Valuation
Munjal Mahendrabhai Patel
12.91 %
2,585,500 12.91 % 18 M ₹
Ashish Rajanibhai Patel
9.135 %
1,829,802 9.135 % 13 M ₹
Rajnibhai G Patel
3.778 %
756,801 3.778 % 5 M ₹
Mahendrabhai Gulabda Patel
3.370 %
675,000 3.370 % 5 M ₹
Sunmed Corp. Llp
2.496 %
500,000 2.496 % 4 M ₹
Kailashben Manibhai Patel
2.396 %
480,000 2.396 % 3 M ₹
Downtown Travels LLP
2.371 %
475,000 2.371 % 3 M ₹
Hashmukhbhai I Patel
1.865 %
373,600 1.865 % 3 M ₹
Anand Anilbhai Patel
1.658 %
332,000 1.658 % 2 M ₹
Kalpanaben Rameshbhai Patel
1.463 %
293,100 1.463 % 2 M ₹

Company contact information

Lincoln Pharmaceuticals Ltd.

Lincoln House Behind Satyam Complex

380060, Ahmedabad

+91 79 4107 8000

http://www.lincolnpharma.com
address Lincoln Pharmaceuticals Limited(LINCOLN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 690B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.03% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 235B
NOVARTIS AG Stock Novartis AG
+5.43% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.86% 195B
AMGEN INC. Stock Amgen Inc.
+3.98% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LINCOLN Stock
  4. LINCOLN Stock
  5. Company Lincoln Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW